CollPlant Biotechnologies
CLGN
CLGN
15 hedge funds and large institutions have $33.1M invested in CollPlant Biotechnologies in 2021 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
36% less capital invested
Capital invested by funds: $51.9M → $33.1M (-$18.8M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
15
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$3.23M | |
| 2 | +$1.04M | |
| 3 | +$689K | |
| 4 |
SPC
Sigma Planning Corp
Ann Arbor,
Michigan
|
+$315K |
| 5 |
PA
Parallel Advisors
San Francisco,
California
|
+$287K |
Top Sellers
| 1 | -$11.6M | |
| 2 | -$4.99M | |
| 3 | -$441K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$276K |
| 5 |
BFEC
Benjamin F. Edwards & Company
St. Louis,
Missouri
|
-$118K |